Review of Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis

Post-publication Review of

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis

Reviewed On January 02, 2021

Reviewed by

Actions

Content of review 1, reviewed on January 02, 2021

The article has been written very well and brings new insights into the area.

Source

References

M., T. I., Zakariya, K., Moussab, D., Muhammad, R., Haytham, T., Mustafa, A., Youssef, A., Mohamad, A., Rana, T., Leslie, H., Tarek, K. 2021. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clinical Microbiology and Infection.